Company Overview and News

14
Russia Joins in on Retaliation Threats for U.S. Tariffs - Bloomberg

15h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BAMXY TM BMWYY TYT BYMOF TOYOF DDAIF BAMXF VLKAF GM.WS.A GM.WS.B GM.WS.C 7203 GM GM.WSB

4
CarMax's (KMX) Q1 Earnings & Revenues Beat Estimates, Up Y/Y

17h zacks
CarMax Inc. (KMX - Free Report) posted adjusted earnings per share of $1.33 in the first quarter of fiscal 2019 (ended May 31, 2018), up 17.7% from $1.13 in the year-ago quarter. Moreover, earnings surpassed the Zacks Consensus Estimate of $1.21.
OSK KMX TM 7203 TYT CAXPF TOYOF

13
New Strong Buy Stocks for June 22nd

18h zacks
Delphi Technologies PLC (DLPH - Free Report) : This company that design, development, and manufacture of integrated powertrain technologies has seen the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.
NOG TM ENSG 7203 TYT TOYOF DLPH MEOH

5
'Zero' chance of Renault taking over Nissan, Mitsubishi: Ghosn - Channel NewsAsia

22h channelnewsasia
Renault SA absorbing Nissan Motor Co. and Mitsubishi Motors Corp is not an option as the carmakers look to strengthen their partnership while retaining their autonomy, alliance chairman Carlos Ghosn said on Friday.
VLKAF MMTOY TM 7203 TYT RNO TOYOF 7211 MMTOF

5
'Zero' chance of Renault taking over Nissan, Mitsubishi: Ghosn

22h reuters
TOKYO (Reuters) - Renault SA (RENA.PA) absorbing Nissan Motor Co. (7201.T) and Mitsubishi Motors Corp (7211.T) is not an option as the carmakers look to strengthen their partnership while retaining their autonomy, alliance chairman Carlos Ghosn said on Friday.
VLKAF MMTOY TM 7203 TYT RNO TOYOF 7211 MMTOF

11
The toll of Trump’s trade war: Damage to more than just Daimler

22h malaymail
MUNICH, June 22 — Over the past three decades, the global auto industry has gotten, well, more global. Manufacturers built scores of factories outside their home countries to reduce exposure to currency swings, take advantage of cheaper labour and manufacture cars closer to buyers.
HYUO TM TYT KIMTY TOYOF DDAIF HYUD GM.WS.A KIMTF GM.WS.B GM.WS.C 7203 HYUP GM GM.WSB

6
Nikkei slips as trade war fears dent automakers

2018-06-22 reuters
TOKYO (Reuters) - Japan’s Nikkei share average dropped on Friday as shares of automakers fell after Germany’s Daimler cut its profit forecast citing tariff concerns, while weak U.S. economic data dampened investor sentiment.
7261 JAPAF MZDAY JAPAY TM MZDAF UNICY 7203 2914 TYT TOYOF UNCHF

6
Nikkei falls on trade war worries; automakers underperform

2018-06-22 malaymail
TOKYO, June 22 — Japan’s Nikkei share average dropped this morning after Germany’s Daimler cut its profit forecasts citing tariff concerns and some US data came in below expectations, hurting cyclical stocks.
7261 JAPAF MZDAY JAPAY TM MZDAF UNICY 7203 2914 TYT TOYOF UNCHF

6
Nikkei falls on trade war worries

2018-06-22 thehindubusinessline
Japan's Nikkei share average dropped on Friday morning after Germany's Daimler cut its profit forecasts citing tariff concerns and some US data came in below expectations, hurting cyclical stocks.
7261 JAPAF MZDAY JAPAY TM MZDAF UNICY 7203 2914 TYT TOYOF UNCHF

6
Nikkei falls on trade war worries; automakers underperform

2018-06-22 reuters
TOKYO (Reuters) - Japan’s Nikkei share average dropped on Friday morning after Germany’s Daimler cut its profit forecasts citing tariff concerns and some U.S. data came in below expectations, hurting cyclical stocks.
7261 JAPAF MZDAY JAPAY TM MZDAF UNICY 7203 2914 TYT TOYOF UNCHF

4
Ford Emerges From Quality Crucible With Less Fussy Tech Features - Bloomberg

2018-06-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TM 7203 TYT TOYOF

11
Volkswagen's (VLKAY) Audi Collaborates With Hyundai for FCEV

2018-06-21 zacks
Volkswagen AG’s (VLKAY - Free Report) Audi AG has agreed on a deal with Hyundai Motor Company to develop fuel-cell technology. Subject to approval from regulatory authorities, both the companies will team up to develop hydrogen vehicle technology to facilitate volume production in a quicker and efficient way.
VLKAF HYUO TM UG 7203 TYT HYUP TOYOF VLKAY HYUD

4
BOJ’s Funo urges continued easing as inflation still weak

2018-06-21 malaymail
SENDAI, June 21 — Bank of Japan board member Yukitoshi Funo said today that the central bank needs to patiently continue its strong monetary easing under the current policy, as slowing inflation keeps the BOJ’s 2 per cent price target a distant objective.
TM 7203 TYT TOYOF

4
BOJ's Funo calls for strong easing to hit 2% inflation as prices weak

2018-06-21 theedgemarkets
SENDAI, Japan (June 21): Bank of Japan board member Yukitoshi Funo said on Thursday that the central bank needs to patiently continue its strong monetary easing under the current policy framework, underscoring the BOJ's resolve to hit its 2% inflation target.
TM 7203 TYT TOYOF

4
Toyota captures data goldmine in US$1b Grab bet

2018-06-21 malaymail
TOKYO, June 21 — By pumping US$1 billion (RM4 billion) into ride-hailing firm Grab, Toyota Motor Corp stands to gain a passenger-side view of tens of thousands of cars across South-east Asia, tracking how fast they drive, how far they travel and the time they spend stuck in traffic.
TM 7203 TYT TOYOF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 089233130